UTHR
United Therapeutics
$527.94
−$0.53 (−0.1%)Jul 27, 2026
Key metrics
The numbers that frame UTHR today
- Market cap
- $22.41B
- P/E (TTM)
- 17.4
- EV / FCF
- 20.8
- Gross margin
- 86.6%
- EV / Sales
- 6.7
- ROIC
- 30.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $272.12
- 52wk High
- $609.35
Growth
Revenue and earnings trend for UTHR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about UTHR
Is United Therapeutics a good buy?
Yes. United Therapeutics has excellent quality and excellent momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think United Therapeutics is selling at a low price.
What is the market capitalization of UTHR?
United Therapeutics's market capitalization is $22.41B.
What is the P/E ratio for UTHR stock?
United Therapeutics's current P/E ratio is 17.4.
What is the 52-week high for UTHR stock?
The 52-week high for United Therapeutics is $609.35. The current close of $527.94 is 13.4% below that high.
What is the 52-week low for UTHR stock?
The 52-week low for United Therapeutics is $272.12. The current close of $527.94 is 94% above that low.
Does UTHR stock pay dividends?
United Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for UTHR?
United Therapeutics's Debt / Equity ratio is 0.